|
|
|
Insider
Information: |
Dovey Brian H |
Relationship: |
Director |
City: |
Princeton |
State: |
NJ |
|
|
Insider
Summary: |
|
|
|
Companies Owned : |
26 |
|
Direct
Shares |
22,997 |
|
Indirect Shares
|
3,240,409 |
|
|
Direct
Value |
$7,480 |
|
|
Indirect Value
|
$11,483,824 |
|
|
Total
Shares |
3,263,406 |
|
|
Total
Value |
$11,491,304 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
Total
Filings :
|
0
|
0
|
Stock
price went up :
|
0
|
0
|
Stock
price went down : |
0
|
0
|
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
Percentage
Gain/Loss : |
0.0%
|
0.0%
|
|
|
|
|
|
|
Holdings
:
Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold |
|
Align Technology Inc |
ALGN |
Director |
2003-08-08 |
0 |
2003-08-08 |
0 |
Premium* |
|
Senomyx Inc |
SNMX |
10% Owner |
|
0 |
2004-06-25 |
19,603 |
Premium* |
|
Nuvasive Inc |
NUVA |
10% Owner |
|
0 |
2004-05-18 |
31,204 |
Premium* |
|
Santarus Inc |
SNTS |
10% Owner |
2004-04-06 |
0 |
2004-04-06 |
64,471 |
Premium* |
|
Somaxon Pharmaceuticals, Inc. |
SOMX |
10% Owner |
|
0 |
2006-12-21 |
19,379 |
Premium* |
|
Vanda Pharmaceuticals Inc. |
VNDA |
10% Owner |
2006-04-18 |
0 |
2006-12-12 |
21,068 |
Premium* |
|
Northstar Neuroscience Inc |
NSTR |
10% Owner |
|
0 |
2006-05-10 |
37,586 |
Premium* |
|
Paratek Pharmaceuticals Inc |
PRTK |
10% Owner |
2006-05-15 |
0 |
2009-01-30 |
67,875 |
Premium* |
|
Volcano Corp |
VOLC |
10% Owner |
2008-06-03 |
0 |
2008-07-16 |
62,513 |
Premium* |
|
Cadence Pharmaceuticals Inc |
CADX |
10% Owner |
|
0 |
2014-03-19 |
0 |
Premium* |
|
Neose Technologies Inc |
NTEC |
Director |
2009-01-27 |
2,869 |
2007-03-09 |
79,041 |
Premium* |
|
Orexigen Therapeutics, Inc. |
OREX |
Director |
2007-11-27 |
20,128 |
2014-04-22 |
129,448 |
Premium* |
|
Alimera Sciences Inc |
ALIM |
10% Owner |
2010-04-27 |
0 |
2011-06-02 |
40,790 |
Premium* |
|
Achillion Pharmaceuticals Inc |
ACHN |
10% Owner |
|
0 |
2013-01-18 |
244,057 |
Premium* |
|
Zogenix, Inc. |
ZGNX |
10% Owner |
2010-11-29 |
0 |
2011-09-16 |
169,251 |
Premium* |
|
Clovis Oncology, Inc. |
CLVS |
10% Owner |
2011-11-21 |
0 |
2011-11-21 |
51,013 |
Premium* |
|
Durata Therapeutics, Inc. |
DRTX |
10% Owner |
|
0 |
2012-07-24 |
22,306 |
Premium* |
|
Esperion Therapeutics, Inc. |
ESPR |
10% Owner |
|
0 |
2013-07-01 |
35,253 |
Premium* |
|
Ocera Therapeutics Inc |
OCRX |
10% Owner |
2013-07-15 |
0 |
2013-07-15 |
1,920,730 |
Premium* |
|
Tobira Therapeutics Inc |
TBRA |
10% Owner |
|
0 |
2013-08-27 |
32,091 |
Premium* |
|
Evoke Pharma Inc |
EVOK |
10% Owner |
|
0 |
2013-09-30 |
24,256 |
Premium* |
|
Veracyte, Inc. |
VCYT |
10% Owner |
2013-11-04 |
0 |
2013-11-04 |
22,730 |
Premium* |
|
Tandem Diabetes Care Inc |
TNDM |
10% Owner |
2013-11-19 |
0 |
2013-11-19 |
54,390 |
Premium* |
|
Dicerna Pharmaceuticals Inc |
DRNA |
10% Owner |
2014-02-04 |
0 |
2014-02-04 |
13,004 |
Premium* |
|
Achaogen Inc |
AKAO |
10% Owner |
2014-03-17 |
0 |
2014-03-17 |
33,890 |
Premium* |
|
Otonomy, Inc. |
OTIC |
Director |
2015-05-28 |
0 |
2015-05-28 |
44,460 |
Premium* |
|
|
|
|
|
|
|
|
|
|
Records found :
131 |
Free Registration Required For Full Results. Limit: 25
|
|
Download |
Page 2 of 6
|
Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
3m +/- |
|
|
Form |
ALIM |
Alimera Sciences Inc |
10% Owner |
|
2011-06-02 |
4 |
A |
$0.00 |
$0 |
I/I |
18,864 |
18,864 |
0 |
- |
|
EVOK |
Evoke Pharma Inc |
10% Owner |
|
2013-09-30 |
4 |
A |
$0.00 |
$0 |
I/I |
1,133,333 |
19,006 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-07-23 |
4 |
B |
$7.50 |
$4,875,000 |
I/I |
650,000 |
19,138 |
2.25 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
officerTitle |
|
2005-12-14 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
19,166 |
|
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-12-21 |
4 |
S |
$13.52 |
$87,326 |
I/I |
(6,459) |
19,379 |
0 |
- |
|
SNMX |
Senomyx Inc |
10% Owner |
|
2004-06-25 |
4 |
A |
$0.00 |
$0 |
I/I |
1,490,870 |
19,603 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2007-11-27 |
4 |
A |
$0.00 |
$0 |
D/D |
20,128 |
20,128 |
0 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-05-29 |
4 |
S |
$14.14 |
$116,104 |
D/D |
(8,200) |
20,260 |
0 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
A |
$0.00 |
$0 |
I/I |
9,783 |
20,458 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-08-11 |
4 |
B |
$7.60 |
$792,680 |
I/I |
104,300 |
20,887 |
2.25 |
- |
|
VNDA |
Vanda Pharmaceuticals Inc... |
10% Owner |
|
2006-12-12 |
4 |
S |
$25.62 |
$330,498 |
I/I |
(12,900) |
21,068 |
0 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-06-25 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
21,471 |
|
- |
|
DRTX |
Durata Therapeutics, Inc. |
10% Owner |
|
2012-07-24 |
4 |
B |
$9.00 |
$7,058,817 |
I/I |
784,313 |
22,306 |
1.5 |
- |
|
VCYT |
Veracyte, Inc. |
10% Owner |
|
2013-11-04 |
4 |
A |
$0.00 |
$0 |
I/I |
3,086,024 |
22,730 |
0 |
- |
|
ACHN |
Achillion Pharmaceuticals... |
10% Owner |
|
2010-10-06 |
4 |
A |
$0.00 |
$0 |
I/I |
25,000 |
25,000 |
0 |
- |
|
SOMX |
Somaxon Pharmaceuticals, ... |
10% Owner |
|
2006-09-18 |
4 |
S |
$13.03 |
$84,161 |
I/I |
(6,459) |
25,838 |
0 |
- |
|
CADX |
Cadence Pharmaceuticals I... |
10% Owner |
|
2006-10-24 |
3 |
IO |
$0.00 |
$0 |
I/I |
0 |
27,500 |
|
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-08-12 |
4 |
B |
$8.00 |
$3,200,000 |
I/I |
400,000 |
27,595 |
2.25 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-08-13 |
4 |
B |
$7.85 |
$102,050 |
I/I |
13,000 |
27,813 |
2.25 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-08-14 |
4 |
B |
$8.00 |
$209,800 |
I/I |
26,225 |
28,253 |
2.25 |
- |
|
VOLC |
Volcano Corp |
10% Owner |
|
2008-04-24 |
4 |
A |
$0.00 |
$0 |
D/D |
28,460 |
28,460 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-08-17 |
4 |
B |
$7.64 |
$482,856 |
I/I |
63,201 |
29,313 |
2.25 |
- |
|
ESPR |
Esperion Therapeutics, In... |
10% Owner |
|
2013-07-01 |
4 |
A |
$0.00 |
$0 |
I/I |
1,816,474 |
30,462 |
0 |
- |
|
OREX |
Orexigen Therapeutics, In... |
Director |
|
2009-11-10 |
4 |
B |
$6.93 |
$584,892 |
I/I |
84,400 |
30,959 |
2.25 |
- |
|
NUVA |
Nuvasive Inc |
10% Owner |
|
2004-05-18 |
4 |
A |
$0.00 |
$0 |
I/I |
1,657,444 |
31,204 |
|
- |
|
131 Records found
|
|
Page 2 of 6 |
|
Free Registration Required For Full Results. Limit: 25
|
|
|
Transaction Code Key: |
Ownership Code Key |
|
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
|
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
|
IO |
- Initital Ownership |
D |
- Disposed |
|
|
|
|
|
|